7 Predictions for the Cannabidiol Industry in 2020

January 2, 2020 16:00:39

If you’ve been paying even the slightest attention to the news, you have undoubtedly heard about cannabidiol, more commonly known as CBD. The market for the hemp extract blew up after the 2018 Farm Bill legalized cultivating industrial hemp, with experts saying it will hit at least $20 billion by 2026.

CBD has made quite a name for itself in the medical, sports, and health and wellness communities. The compound is a potent medicine, said to be effective against a plethora of diseases. Last year, the FDA approved a CBD based drug to treat seizures in severe childhood epilepsies. CBD is clearly here to stay. Several predictions have been made for…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.